The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Dementia death rates stable between 2018 and 2019, then increased in 2020, and declined in 2022, with the rate higher than 2018, 2019 ...

Catriona Reddin, MB, BCh, from the University of Galway in Ireland, and colleagues examined whether the importance of individual risk factors for stroke differ by stroke severity. Stroke severity was ...